360 related articles for article (PubMed ID: 28134226)
21. Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.
Schaer BA; Osswald S; Di Valentino M; Soliman OI; Sticherling C; ten Cate FJ; Jordaens L; Theuns DA
Eur J Heart Fail; 2010 Dec; 12(12):1325-32. PubMed ID: 20923856
[TBL] [Abstract][Full Text] [Related]
22. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
23. The Necessity of an ICD-Therapy in Patients with Indications for Primary Prevention of Sudden Cardiac Death. One Center Experience.
Postol AS; Neminushchiy NM; Antipov GN; Ivanchenko AV; Lyashenko VV; Vygovsky AB; Shnejder YA
Kardiologiia; 2021 May; 61(4):24-31. PubMed ID: 33998405
[TBL] [Abstract][Full Text] [Related]
24. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
26. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
[TBL] [Abstract][Full Text] [Related]
27. Implantable cardioverter/defibrillator interventions in primary prevention: do current implantation criteria really predict ICD interventions?
Cools T; Rossenbacker T; Floré V; Nuyens D; Heidbochel H; Willems R
Acta Cardiol; 2011 Apr; 66(2):145-51. PubMed ID: 21591571
[TBL] [Abstract][Full Text] [Related]
28. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404
[TBL] [Abstract][Full Text] [Related]
29. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
30. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
31. Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator.
Sabbag A; Glikson M; Suleiman M; Boulos M; Goldenberg I; Beinart R; Nof E
Heart Rhythm; 2019 Jun; 16(6):813-819. PubMed ID: 31153454
[TBL] [Abstract][Full Text] [Related]
32. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
33. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
38. The implantable cardioverter defibrillator in primary prevention: a revision of monocentric study group.
Gigli L; Barabino D; Sartori P; Rossi P; Reggiardo G; Chiarella F; Rosa GM; Bertero G
J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):653-8. PubMed ID: 24983347
[TBL] [Abstract][Full Text] [Related]
39. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.
Bortnik M; Degiovanni A; Dell'era G; Cavallino C; Occhetta E; Marino P
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):301-6. PubMed ID: 23811840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
